Skip to content

Depdc5 Related Hemimegalencephaly Cn381427

Published: July 22, 2026Updated: August 20, 2026

A rare brain malformation where one hemisphere is enlarged, causing seizures and developmental challenges. Treatment involves seizure control and, in some cases, surgical intervention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q04.5
ICD-11
LA00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Refractory focal seizures

!

Hemiparesis

!

Increased intracranial pressure

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hemispherectomy or hemispherotomy

Surgical disconnection or removal of the enlarged hemisphere to eliminate seizure onset in severe, medication-resistant cases of hemimegalencephaly.

surgical
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Aggressive antiepileptic drug regimen

Combination therapy with multiple antiepileptic medications to achieve seizure control, often necessary pre-operatively and when surgery is not feasible.

medication

Additional treatment options

mTOR pathway inhibition

Everolimus or sirolimus therapy to potentially reduce abnormal brain growth and seizure burden by modulating cellular proliferation pathways.

medication

Intensive early intervention therapy

Comprehensive rehabilitation program addressing hemiparesis, developmental delays, and functional limitations through targeted exercises and adaptive techniques.

physical_therapy

Serial neuroimaging and EEG surveillance

Regular MRI imaging to monitor progression of megalencephaly and EEG monitoring to characterize seizure patterns and treatment response.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Depdc5 Related Hemimegalencephaly Cn381427?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Depdc5 Related Hemimegalencephaly Cn381427. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy